Hisamitsu Pharmaceutical Co., Inc. (HTSUF)
USD 24.56
(0.0%)
USD 24.56
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 18.18 Billion | 12.72 Billion | 19.19 Billion | 5.28 Billion | 27.39 Billion | 15.77 Billion |
| Net Income | 13.97 Billion | 16.11 Billion | 12.95 Billion | 12.19 Billion | 26.15 Billion | 25.67 Billion |
| Depreciation & Amortization | 5.17 Billion | 4.95 Billion | 4.32 Billion | 4.07 Billion | 4.25 Billion | 5.74 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.31 Billion | -262 Million | 4.29 Billion | -2.39 Billion | -1.38 Billion | -4.87 Billion |
| Other non-cash items | 13.72 Billion | -8.07 Billion | -2.36 Billion | -8.59 Billion | -1.62 Billion | -10.77 Billion |
| Investing Cash Flow | -2.51 Billion | -23.86 Billion | -13.06 Billion | 7.81 Billion | -17.22 Billion | -39.3 Billion |
| Investments in PPE | -13.03 Billion | -7.9 Billion | -4.19 Billion | -3.38 Billion | -3.72 Billion | -3.66 Billion |
| Acquisitions | -6.61 Billion | 957 Million | -544 Million | 597 Million | 74 Million | -247 Million |
| Investment purchases | -15 Million | -5.89 Billion | -340 Million | -191 Million | -11.12 Billion | -883 Million |
| Sales/Maturities of investments | 17.12 Billion | 1.99 Billion | 2.44 Billion | 10.92 Billion | -46 Million | 1.89 Billion |
| Other Investing Activities | 27 Million | -13.01 Billion | -10.42 Billion | -129 Million | -2.4 Billion | -36.4 Billion |
| Financing Cash Flow | -16.69 Billion | -14.68 Billion | -15.18 Billion | -7.18 Billion | -11.72 Billion | -13.34 Billion |
| Debt repayment | -70 Million | -71 Million | -77 Million | -69 Million | -67 Million | -71 Million |
| Dividends payments | -6.57 Billion | -6.71 Billion | -6.83 Billion | -6.8 Billion | -6.83 Billion | -6.88 Billion |
| Common Stock Repurchased | -9.79 Billion | -7.69 Billion | -8.04 Billion | -2 Million | -4.52 Billion | -6.17 Billion |
| Common Stock Issuance | - | -61 Million | -84 Million | -215 Million | -204 Million | -168 Million |
| Other Financing Activities | -244 Million | -142 Million | -146 Million | -95 Million | -99 Million | -50 Million |
| Accounts receivables | -2.08 Billion | 780 Million | 2.19 Billion | 8.95 Billion | -9.42 Billion | -5.31 Billion |
| Accounts payables | 686 Million | 653 Million | -2.19 Billion | -3.81 Billion | 4.94 Billion | 649 Million |
| Inventory | -1.62 Billion | -1.58 Billion | 3.07 Billion | -4.32 Billion | 232 Million | 1.31 Billion |
| Other working capital | 1.71 Billion | -114 Million | 1.22 Billion | -3.21 Billion | 2.85 Billion | -6.18 Billion |
| Cash at beginning of period | 65.42 Billion | 86.24 Billion | 91.35 Billion | 86.99 Billion | 88.78 Billion | 126.56 Billion |
| Cash at end of period | 53.92 Billion | 65.42 Billion | 86.24 Billion | 91.35 Billion | 86.99 Billion | 88.78 Billion |
| Capital Expenditure | -13.03 Billion | -7.9 Billion | -4.19 Billion | -3.38 Billion | -3.72 Billion | -3.66 Billion |
| Effect of forex changes on cash | 1.95 Billion | 5 Billion | 3.94 Billion | -1.55 Billion | -225 Million | -908 Million |
| Net cash flow / Change in cash | -11.5 Billion | -20.82 Billion | -5.1 Billion | 4.35 Billion | -1.78 Billion | -37.78 Billion |
| Free Cash Flow | 5.15 Billion | 4.81 Billion | 15 Billion | 1.9 Billion | 23.66 Billion | 12.1 Billion |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.85 Billion | 13.97 Billion | 3.69 Billion | 4.36 Billion | 4.04 Billion | 16.11 Billion |
| Depreciation & Amortization | - | 5.17 Billion | 1.16 Billion | 1.32 Billion | 1.14 Billion | 4.95 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -1.31 Billion | - | - | - | -262 Million |
| Other non-cash items | -1.85 Billion | 13.72 Billion | -3.69 Billion | -4.36 Billion | -4.04 Billion | -8.07 Billion |
| Investing Cash Flow | - | -2.51 Billion | - | - | - | -23.86 Billion |
| Investments in PPE | - | -13.03 Billion | - | - | - | -7.9 Billion |
| Acquisitions | - | -6.61 Billion | - | - | - | 957 Million |
| Investment purchases | - | -15 Million | - | - | - | -5.89 Billion |
| Sales/Maturities of investments | - | 17.12 Billion | - | - | - | 1.99 Billion |
| Other Investing Activities | - | 27 Million | - | - | - | -13.01 Billion |
| Financing Cash Flow | - | -16.69 Billion | - | - | - | -14.68 Billion |
| Debt repayment | - | -70 Million | - | - | - | -71 Million |
| Dividends payments | - | -6.57 Billion | - | - | - | -6.71 Billion |
| Common Stock Repurchased | - | -9.79 Billion | - | - | - | -7.69 Billion |
| Common Stock Issuance | - | - | - | - | - | -61 Million |
| Other Financing Activities | - | -244 Million | - | - | - | -142 Million |
| Accounts receivables | - | -2.08 Billion | - | - | - | 780 Million |
| Accounts payables | - | 686 Million | - | - | - | 653 Million |
| Inventory | - | -1.62 Billion | - | - | - | -1.58 Billion |
| Other working capital | - | 1.71 Billion | - | - | - | -114 Million |
| Cash at beginning of period | - | 65.42 Billion | 81.18 Billion | 122.3 Billion | 65.42 Billion | 86.24 Billion |
| Cash at end of period | - | 53.92 Billion | 111.14 Billion | 81.18 Billion | 122.3 Billion | 65.42 Billion |
| Capital Expenditure | - | -13.03 Billion | - | - | - | -7.9 Billion |
| Effect of forex changes on cash | - | 1.95 Billion | - | - | - | 5 Billion |
| Net cash flow / Change in cash | - | -11.5 Billion | 29.95 Billion | -41.11 Billion | 56.87 Billion | -20.82 Billion |
| Free Cash Flow | - | 5.15 Billion | 2.33 Billion | 2.64 Billion | 2.29 Billion | 4.81 Billion |
4687
BVS
VOPKY
6248
O10
ACPS